Genelux Investor Presentation Deck
December 2023, 37 slides
  1. Genelux
  2. Related Decks
  3. Investor Presentation Decks
redefining oncology | Genelux
forward looking statements | Genelux
highlights | Genelux
the most advanced non local delivery completed clinical trials patients | Genelux
program builds on completed trials to exploit competitive advantages estimated billion dollar plus annual commercial opportunity us | Genelux
selective replication in tumors unleashes immune system against cancer | Genelux
primed overcoming drug resistance | Genelux
a maturing modality with phase companies validating potential gene | Genelux
phase anti tumor activity as leading into combination a | Genelux
completed phase tested primed heavily patients with platinum resistant or platinum refractory ovarian cancer published in jama oncology link | Genelux
phase clinically meaningful responses in heavily patients | Genelux
demonstrated deep and durable tumor shrinkage | Genelux
primed overcomes refractoriness exemplary platinum refractory patients after platinum challenge achieved exceeding any prior lines | Genelux
durable survival benefit | Genelux
approach may reset life clock of heavily treated patients | Genelux
phase pivotal trial design founded on phase trial design results trial design intends to replicate previous data showing anti tumor activity of and reversal of platinum resistance in the tumor | Genelux
systemic administration demonstrated dose dependent benefit | Genelux
systemic administration generated encouraging data expanded access program | Genelux
has partnered with top | Genelux
validating industry collaboration with excluding greater china to all data generated | Genelux
act therapeutics joint venture between and | Genelux
self launch for ovarian cancer in the us | Genelux
integrated and manufacturing capabilities for phase and launch | Genelux
choice platform library vectors with | Genelux
intellectual property market exclusivity freedom to operate strong regulatory designations | Genelux
accomplished leadership team | Genelux
expected operating runway into | Genelux
has executed on multiple milestones and is positioned for the future a | Genelux
highlights | Genelux
redefining oncology | Genelux
accomplished clinical advisory board | Genelux
primed anti tumor activity primed | Genelux
primed overcomes refractoriness | Genelux
demonstrates and immune activation patient samples | Genelux
cells infiltrating lymphocytes are prognostic for response survival | Genelux
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
ideal backbone for combination therapy converts tumor to inflammatory hot spot pee | Genelux
See More
Genelux
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Tumor
Ovarian
Lung
Ovarian cancer
Cell therapy
Recent decks by Genelux
Investor Presentation
February 2024
Investor Presentation
October 2023
Investor Presentation
July 2023
See all presentations by Genelux (4 decks)
Related decks
Immatics
Investor Presentation
November 2023
AstraZeneca
Investor Event
June 2023
Nuvectis Pharma
Investor Presentation
January 2024
TCR2 Therapeutics
Results
September 2022
Exscientia
Results
August 2023
Alkermes
Investor Presentation
October 2023
Allarity Therapeutics
Investor Conference
September 2022
Alkermes
Investor Day
March 2021
Recent decks by Genelux
See all presentations (4 decks)
Investor Presentation
February 2024
Investor Presentation
October 2023
Investor Presentation
July 2023
Immatics
Investor Presentation
November 2023
AstraZeneca
Investor Event
June 2023
Nuvectis Pharma
Investor Presentation
January 2024
TCR2 Therapeutics
Results
September 2022
Exscientia
Results
August 2023
Alkermes
Investor Presentation
October 2023
Allarity Therapeutics
Investor Conference
September 2022
Alkermes
Investor Day
March 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io